India's Richest People 2026 edition · 1 director · Source: Hurun India
- #272 CC Paarthipan & family ₹13,800 Cr
Revenue · FY 2025
₹377.24 Cr
▲ 18% YoY
Net profit · FY 2025
₹48.92 Cr
Net margin 13%
EBITDA · FY 2025
₹115.91 Cr
EBITDA margin 30.7%
Authorised capital
₹190 Cr
Registered with MCA
Paid-up capital
₹179.96 Cr
Issued & subscribed
Open charges
₹4.94 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
1,003
Provident fund records
About Caplin Steriles Limited
Data last updated:
Caplin Steriles Limited is a public limited company based in Chennai, Tamil Nadu, India, a subsidiary of Caplin Point Laboratories Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2018 and has been in existence for over 8 years.
Its director CC Paarthipan and family are #272 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24304TN2018PLC126270. Its GSTIN is 33AAHCC9057F1ZN (Tamil Nadu).
The company has an authorised share capital of ₹190 Cr and a paid-up capital of ₹179.96 Cr. It is led by directors including Sridhar Ganesan (Whole-Time Director) and Komattu Chacko John.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹377.24 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹48.92 Cr (net margin 13%) and EBITDA of ₹115.91 Cr (EBITDA margin 30.7%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 39% over five years.
The company has about 1,003 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Caplin Steriles. As per MCA filings, the company has open charges of ₹4.94 Cr on record. Court records list 8 cases involving the company, including 6 filed by the company and 2 filed against it; 2 cases are pending. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹311.3 Cr; the latest was in March 2020. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Hetero Biopharma Limited with revenue of ₹387.48 Cr.
For more details, the company can be reached via its website caplinsteriles.net.
Company details
CIN U24304TN2018PLC126270
Registration Number 126270
Incorporation Date 12 December 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 08 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Caplin Point Laboratories Limited
Key People
Sridhar Ganesan Whole-Time Director Komattu Chacko John Director Prem Venkatachalam Pavoor Nominee Director Recognitions & Rankings of Caplin Steriles
Contact details
Caplin Steriles Limited's registered office is in Chennai, Tamil Nadu. Its website is caplinsteriles.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Floor Ashvich Towers No.3 Developed Plots Industrial Estates Per, Ungudi, Chennai, Tamil Nadu, India – 600096
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Caplin Steriles Limited, buy the company report.
Comprehensive company report
Caplin Steriles Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Caplin Steriles operates one associated brand: Caplin Steriles. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer and manufacturer of injectable products in vials, vyophilized vials and ophthalmic drops | caplinsteriles.net |
Business activity
The main business activity of Caplin Steriles is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Caplin Steriles Limited, buy the company report.
Financials of Caplin Steriles Limited
FY 2025 filings availableCaplin Steriles Limited reported revenue of ₹377.24 Cr (up 18% YoY) for FY 2025.
Revenue · FY 2025
₹377.24 Cr ▲ 18%
Net profit · FY 2025
₹48.92 Cr margin 13%
EBITDA · FY 2025
₹115.91 Cr margin 30.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 43%
5 years · compounded
▲ 39%
EBITDA CAGR growth
1 year
▲ 89%
3 years · compounded
▲ 123%
5 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 18% growth in the latest year. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹115.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.7% | ||||
| Net Profit Margin | 13% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Caplin Steriles Limited, buy the company report.
Board of directors of Caplin Steriles Limited
Caplin Steriles has 8 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komattu Chacko John Also directs: Caplin Point Laboratories Limited | Director | 08 Aug 2019 | 7 Years 2 Months | Current |
| Prem Venkatachalam Pavoor Also directs: Laurus Bio Private Limited, Immuneel Therapeutics Private Limited, Enzene Biosciences Limited and 3 more | Nominee Director | 07 Mar 2019 | 7 Years 7 Months | Current |
| Rengaraj Viswanathan | Director | 04 Jul 2023 | 3 Years 3 Months | Current |
| Ketan Mahendra Patel | Nominee Director | 02 Nov 2023 | 2 Years 11 Months | Current |
| Sridhar Ganesan | Whole-Time Director | 13 Jun 2022 | 4 Years 4 Months | Current |
| Partheeban Vivek Siddarth Also directs: Caplin Point Laboratories Limited, Caplin One Labs Limited, Ashvich Properties Private Limited and 3 more | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Caplin Steriles Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hetero Biopharma Limited | ₹387.48 Cr (FY 2024) | 13.0% | Hyderabad, Telangana, India | |||
| Zim Laboratories Limited. | ₹384.82 Cr (FY 2025) | 3.0% | Nagpur, Maharashtra, India | |||
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Marc Laboratories Limited | ₹383.21 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Caplin Steriles Limitedthis company | ₹377.24 Cr (FY 2025) | ₹48.92 Cr | 13% | 18.0% | 1,003 | Chennai, Tamil Nadu, India |
| NGL Fine-Chem Limited | ₹376.89 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Unicure India Ltd | ₹369.12 Cr (FY 2025) | -12.0% | New Delhi, Delhi, India | |||
| Beta Drugs Limited | ₹368.79 Cr (FY 2025) | 24.0% | Baddi, Himachal Pradesh, India | |||
| Brawn Laboratories Limited | ₹368.56 Cr (FY 2025) | 15.0% | Delhi, India | |||
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India |
To see the full peer comparison of Caplin Steriles Limited, buy the company report.
Auditor
Caplin Steriles Limited is audited by MSKA & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Caplin Steriles Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Caplin Steriles Limited, buy the company report.
Charges & borrowings
Open charges
₹4.94 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2025 | 101067808 | Others | ₹4.94 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Caplin Steriles Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹311.3 Cr; the latest was in March 2020.
Total deals
3
Funding rounds
2
Rights issue
1
Disclosed funding
₹311.3 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Rights issue | ₹35 Cr | Investors: Caplin Point Laboratories Limited |
| Mar 2019 | Funding round · Series A | ₹218 Cr | Investors: Eight Roads Ventures, F-Prime Capital Partners |
| Feb 2019 | Funding round | ₹93.3 Cr | Investors: Caplin Point Laboratories Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Caplin Steriles Limited has 8 court cases on record: 6 filed by Caplin Steriles, 2 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
6
Filed against the company
2
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 1 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case (C.S(COMM DIV)) | Filed by the company against Cholamandalam Ms General Insurance Company Limited | Pending |
| Madras High Court | Appeal | Filed by the company against Cholamandalam Ms General Insurance Company Limited | Disposed |
| High Court, TAMIL NADU | Revision petition | Filed by the company against The Catholic Syrian Bank Ltd2 and 25 others | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against The Catholic Syrian Bank Ltd2 and 25 others | Disposed |
| District court, Tiruvallur, Tamil Nadu | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Caplin Steriles Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Caplin Steriles Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Caplin Steriles has 1 associated company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Caplin Steriles Limited has a workforce of 1,003 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
1,003
Active EPFO establishments
1
Employee growth
14.11%
GST
Caplin Steriles has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCC9057F1ZN | Tamil Nadu | Active | 12 Dec 2018 |
To see the full GST registrations and return filing status of Caplin Steriles Limited, buy the company report.
Recent activity
Caplin Steriles Limited has 15 board changes on record since 2018: 8 appointments and 7 cessations. The latest: Ketan Mahendra Patel was appointed as Nominee Director on 02 Nov 2023.
AGM
Caplin Steriles Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Filing
Caplin Steriles Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 4.94 Cr with Charge ID 101067808 was registered on 27 Mar 2025.
Appointed
Ketan Mahendra Patel was appointed as Nominee Director.
Ceased
Rengaraj Viswanathan ceased to be Additional Director.
Appointed
Rengaraj Viswanathan was appointed as Director.
Ceased
Sridhar Ganesan ceased to be Additional Director.
Appointed
Sridhar Ganesan was appointed as Whole-Time Director.
Ceased
Subramanian Narayanaswamy ceased to be Whole-Time Director.
Ceased
Gariyali Chanderkanta ceased to be Additional Director.
Appointed
Gariyali Chanderkanta was appointed as Director.
Ceased
Desikachari Muralidharan ceased to be Additional Director.
7 earlier events are in the company report.
News
Frequently asked questions
Caplin Steriles is an active public limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U24304TN2018PLC126270.
Caplin Steriles has 8 current directors:
- Sridhar Ganesan - Whole-Time Director
- Komattu Chacko John - Director
- Prem Venkatachalam Pavoor - Nominee Director
- Rengaraj Viswanathan - Director
- Ketan Mahendra Patel - Nominee Director
- Partheeban Vivek Siddarth - Director
- Gariyali Chanderkanta - Director
- Paarthipan Chingelput Chellappan - Director
The latest financial statements of Caplin Steriles on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Caplin Steriles is 33AAHCC9057F1ZN, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Caplin Steriles is U24304TN2018PLC126270. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caplin Steriles has 8 court cases on record: 6 filed by the company and 2 filed against it. 2 are pending. Most are in the high courts.
Caplin Steriles was incorporated on 12 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Caplin Steriles has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹311.3 Cr; the latest was in March 2020.
The peers of Caplin Steriles by revenue are Hetero Biopharma Limited, Zim Laboratories Limited, Rajasthan Antibiotics Ltd, Marc Laboratories Limited, NGL Fine-Chem Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ketan Mahendra Patel was appointed as Nominee Director on 02 Nov 2023. Rengaraj Viswanathan ceased to be Additional Director on 29 Aug 2023. Rengaraj Viswanathan was appointed as Director on 04 Jul 2023. Caplin Steriles has 15 board changes on record in total.
Caplin Steriles can be reached through the website caplinsteriles.net. Its registered office is in Chennai, Tamil Nadu, India.